WASHINGTON - Acting FDA Commissioner Andrew von Eschenbach might be one step closer to Senate approval following reports that the maker of the Plan B contraceptive product, Barr Pharmaceuticals Inc., agreed to file for over-the-counter status for women 18 and older. (BioWorld Today) Read More